Navigation Links
GE Healthcare Presents Interim Data on the Impact of DaTscan™ (Ioflupane I 123 Injection) SPECT Imaging on the Diagnosis and Clinical Management of Patients with Clinically Uncertain Parkinsonian Syndrome
Date:4/13/2011

HONOLULU, April 13, 2011 /PRNewswire/ -- Today, GE Healthcare announced interim results of a recently completed randomized study of the impact of DaTscan™ SPECT imaging on the clinical  management and diagnosis of adult patients who exhibit signs or symptoms of parkinsonian syndromes (PS). The results, presented at the 2011 American Academy of Neurology Meeting, are an important step in documenting the value of DaTscan as an adjunct diagnostic tool for use in  differentiating between PS and disorders such as essential tremor (ET) that have similar symptoms. DaTscan was approved by the US Food and Drug Administration in January 2011.

This multi-center, open label, randomized clinical trial compared the management, diagnosis, confidence of diagnosis (CoD), and quality of life (QoL) at four, 12 weeks and 52 weeks after randomization to either undergo DaTscan SPECT imaging (N=1331 randomized; 119 dosed and scanned) or not (N=136). The full study will evaluate patients through one year from baseline. Interim results showed more patients in the DaTscan group had changes from baseline (pre-DaTscan) diagnosis and their physicians had a higher mean CoD compared with the control group at both four and 12 weeks post-randomization. Additionally, in patients with a management plan at baseline (N=113 DaTscan and 125 control), significantly more DaTscan patients had management changes 12 weeks after randomization (49% vs. 31%) compared to the control group (p=0.004).  

"Interim clinical results show that DaTscan can be useful in providing objective evidence for patients with diagnostic uncertainty," said Frederick Weiland, MD, Sutter Medical Group Diagnostic Medical Imaging Co-Director of Nuclear Medicine. "In addition, physicians of patients participating in the study had more confidence in their diagnosis and recommended treatment when they had a DaTscan image."

Fifty thousand to sixty thousand new cases of Parkinson's disease (PD), a
'/>"/>

SOURCE GE Healthcare
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. ViroPharma to Present at Three Upcoming Healthcare Conferences
4. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
5. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
6. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
7. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
8. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
9. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
10. Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5
11. Immtech to Present at The Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013 Kepner-Tregoe (KT), ... announced that 13-year veteran Chris Geraghty ... Geraghty,s experience includes more than 20 years serving ... with manufacturing organizations. He succeeds Ray ... as Kepner-Tregoe,s Chairman of the Board and CEO. ...
(Date:5/21/2013)... , May 21, 2013  IsoRay, Inc. (AMEX: ... that it has entered into an exclusive international distribution ... complete product line in Greece . ... seed brachytherapy and medical radioisotope applications for brain cancer, ... gynecologic ("gyn") cancer. IASIS Medical is ...
(Date:5/21/2013)... Inc. (OTC BB: VASO) (the "Company"), a diversified medical technology ... devices and in the domestic sale of diagnostic imaging products, ... President and CEO of Vasomedical, Inc. will present at the ... 2013 in New York City at ... is scheduled to begin at 9:30 a.m. EDT. ...
Breaking Medicine Technology:Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 2Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 3IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2
... Nephros, Inc. (OTC Bulletin Board: NEPH ... products for therapeutic applications, infection control, and water purification, ... reverse split of its common stock will take effect ... 2011. Nephros common stock will be quoted on the ...
... The Florida Society of Pain Management Providers ( www.Flspmp.org ... use in the United States. Until now these statistics ...  Oxycodone dispensed in U.S. 2009 by state (per 100,000 ... FDA.Translation from grams to 15mg tablets for comparison purposes ...
Cached Medicine Technology:Nephros Announces Completion of Reverse Stock Split 2Nephros Announces Completion of Reverse Stock Split 3Nephros Announces Completion of Reverse Stock Split 4Florida Pain Clinic Society: 3.7 Billion Oxycodone Tablets Dispensed in U.S. 2
(Date:5/21/2013)... 2013 According to a May 13, 2013 ... of Botox,” Botox injections have become the most ... 2002 (Go to goo.gl/8iYbD). Although it is mostly associated with ... The injection makes facial wrinkles less visible by paralyzing facial ... about three months. This means that people who are conscious ...
(Date:5/21/2013)... 2013 Phoseon Technology will present their ... 20th Annual IMI European Ink Jet Conference (June ... Phoseon continues to invest in product development to enable ... UV LED curing in printing applications. Phoseon currently ... market offering both air cooled and water cooled solutions ...
(Date:5/21/2013)... 2013 MedMar Healing Center announces ... Second Harvest Food Bank. Twenty-eight businesses, including MedMar Healing Center, ... food drive. The goal is to raise food to help ... facing their families in recent years. , “We like ... those in need,” explains Douglas Chloupek of MedMar Healing Center. ...
(Date:5/21/2013)... thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, ... acid fragment of prosaposin that significantly reduces metastatic ... lung cancer. The findings suggest that a prosaposin-based ... of cancers. , The study team, led ... Vivek Mittal, PhD, at Weill Cornell Medical College ...
(Date:5/21/2013)... The Brazilian funding agency for scientific and technological research ... of So Paulo, announced an investment estimated in US$ ... Centers (RIDCs) for a period of up to eleven ... and 7. , Funding for the 17 RIDCs ... funding faculty, technicians, support personnel, and infrastructure). Host institutions ...
Breaking Medicine News(10 mins):Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2Health News:Changing cancer's environment to halt its spread 2Health News:Changing cancer's environment to halt its spread 3Health News:Research at the cutting edge of knowledge 2
... fix for depression. Even if you are under medical care ... ,The December issue of Mayo Clinic Women's HealthSource offers five ... the risk of recurrence. ,1. Keep active. ... most days has been shown to improve mood. Long-term regular ...
... form of food poison. Then, fame came as a ... the 'miracle poison' and used for an increasing number ... of Mayo Clinic Health Letter covers how this drug ... ,Botulinum toxin blocks communication between nerves and muscles. ...
... drugs causing jaw problems have you wondering: Should you stop ... been reports of partial death of a jawbone (osteonecrosis) related ... to the December issue of Mayo Clinic Health Letter. ... — a disease that causes bones to become brittle and ...
... University of Rochester, Low doses of the drug mifepristone ... //and greatly improves the quality of life in women. ... of the journal, Obstetrics and Gynecology. ,Leiomyoma, ... of all women aged 35 to 49. The non-cancerous ...
... by the Department of Radiology at the University of ... the accuracy of diagnosing meniscal tears. ... there is one MR image with an abnormal finding. ... of 174 patients who had knee MR exams then ...
... one more reason why teenage years are perceived as ... the Pandora's Box has opened. //Such teens are prone ... no'vice' contemporaries, a recent insight indicates. ,The Canadian ... abuse tendencies among 15- to 19-year-olds, drawing on the ...
Cached Medicine News:Health News:Five Self-Care Strategies For Depression 2Health News:Mifepristone Reliable For Treating Uterine Fibroids 2Health News:Mifepristone Reliable For Treating Uterine Fibroids 3
DePuy 2 Bone Cement is a unique fast-set digital cement that is the excellent choice for small joint procedures such as the patella, glenoid or other extremity joints....
... Palacos® Bone Cement has clinically proven ... cemented arthroplasty. Palacos® is now available ... an antibiotic loaded bone cement cleared ... of a two-stage revision after infection ...
... System for Two-Dimensional Mapping of the ... uniquely merges two sophisticated measurement techniques, ... flowmetry, to a new kind of ... of the retinal micro-circulation., ,Using an ...
... block tear drainage through the canaliculus, synthetic absorbable ... symptoms:, Indicated for use in the treatment ... components of various ocular surface diseases, May be ... related complications and to enhance the retention of ...
Medicine Products: